The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain
Open accessAbstract
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive decline of cognitive function. There is no therapy that can halt or reverse its progression. Contemporary research suggests that age-dependent neuroinflammatory changes may play a significant role in the decreased neurogenesis and cognitive impairments in AD. The innate immune response is characterized by pro-inflammatory (M1) activation of macrophages and subsequent production of specific cytokines, chemokines, and reactive intermediates, followed by resolution and alternative activation for anti-inflammatory signaling (M2a) and wound healing (M2c). We propose that microglial activation phenotypes are analogous to those of macrophages and that their activation plays a significant role in regulating neurogenesis in the brain. Microglia undergo a switch from an M2- to an M1-skewed activation phenotype during aging. This review will assess the neuroimmunological studies that led to characterization of the different microglial activation states in AD mouse models. It will also discuss the roles of microglial activation on neurogenesis in AD and propose anti-inflammatory molecules as exciting therapeutic targets for research. Molecules such as interleukin-4 and CD200 have proven to be important anti-inflammatory mediators in the regulation of neuroinflammation in the brain, which will be discussed in detail for their therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Chauhan, V. S., Sterka, D. G., Furr, S. R., Young, A. B., & Marriott, I. (2008) · Glia · doi:10.1002/glia.20770 · Cited by 105
The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Colton, C. A., Wilcock, D. M., Wink, D. A., Davis, J., Nostrand, W. E. V., & Vitek, M. P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15405 · Cited by 102
Dok-1 and Dok-2 are negative regulators of T cell receptor signaling
Yasuda, T., Bundo, K., 日野, 昭., Honda, K., Inoue, A., Shirakata, M., Osawa, M., Tamura, T., Nariuchi, H., Oda, H., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm015 · Cited by 101
Yamamoto, M., Kiyota, T., Walsh, S. M., Liu, J., Kipnis, J., & Ikezu, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3877 · Cited by 100
Self-citationLyons, A., McQuillan, K., Deighan, B. F., O’Reilly, J.-A., Downer, E. J., Murphy, A. C., Watson, M., Piazza, A., O’Connell, F., Griffin, R., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.05.060 · Cited by 98 · cited 2×
“These tissues and glia from AD models lack IL - 4 and have enhanced inflammatory responses to LPS ( Lyons et al .”
BackgroundIs Brain Amyloid Production a Cause or a Result of Dementia of The Alzheimer's Type?
Struble, R. G., Ala, T., Patrylo, P. R., Brewer, G. J., & Yan, X. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100846 · Cited by 98
Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling
Shinohara, H., Inoue, A., Toyama‐Sorimachi, N., Nagai, Y., Yasuda, T., Suzuki, H., Horai, R., Iwakura, Y., Yamamoto, T. S., Karasuyama, H., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041817 · Cited by 92
Cole, G. M., & Frautschy, S. A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791011991 · Cited by 92
Maher, F. O., Clarke, R. M., Kelly, A. M., Nally, R. E., & Lynch, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03664.x · Cited by 85
Hatherley, D., & Barclay, A. N. (2004) · European Journal of Immunology · doi:10.1002/eji.200425080 · Cited by 77
Bastos, G. D. N. T., Moriya, T., Inui, F., Katura, T., & Nakahata, N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.020 · Cited by 77
Kiyota, T., Yamamoto, M., Schroder, B., Jacobsen, M. T., Swan, R. J., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · Molecular Therapy · doi:10.1038/mt.2009.44 · Cited by 75
Self-citationBoudakov, I., Liu, J., Fan, N., Gulay, P., Wong, K. K. W., & Gorczynski, R. (2007) · Transplantation · doi:10.1097/01.tp.0000269795.04592.cc · Cited by 73
Non-motor Symptoms of Parkinson's Disease
Chaudhuri, К. R., Tolosa, E., Schapira, A. H. V., & Poewe, W. H. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199684243.001.0001 · Cited by 70
A new role for interferon gamma in neural stem/precursor cell dysregulation
Walter, J., Honsek, S. D., Illes, S., Wellen, J. M., Hartung, H., Rose, C. R., & Dihné, M. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-18 · Cited by 69
Xapelli, S., Bernardino, L. I., Ferreira, R., Grade, S., Silva, A. P., Rosmaninho‐Salgado, J., Cavadas, C., Grouzmann, E., Poulsen, F. R., Jakobsen, B., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06172.x · Cited by 67
Coxibs and Alzheimer's disease: Should they stay or should they go?
Firuzi, O., & Praticò, D. (2006) · Annals of Neurology · doi:10.1002/ana.20774 · Cited by 60
Li, H., Hu, J., Ma, L., Yuan, Z., Wang, Y., Wang, X., Xing, D., Fan, L., & Du, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.023 · Cited by 55
Pillars Article: M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J. Immunol. 2000. 164: 6166–6173
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701141 · Cited by 48
Banerjee, D., & Dick, A. D. (2004) · Ocular Immunology and Inflammation · doi:10.1080/09273940490895326 · Cited by 47
Shiryaev, S. A., Remacle, A. G., Savinov, A. Y., Chernov, A. V., Cieplak, P., Radichev, I., Williams, R. M., Shiryaeva, T. N., Gawlik, K., Postnova, T. I., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041244 · Cited by 46
Figueiredo, C., Pais, T. F., Gomes, J. R., & Chatterjee, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05577.x · Cited by 43
Shein, N. A., Grigoriadis, N., Horowitz, M., Umschwief, G., Alexandrovich, A. G., Simeonidou, C., Grigoriadis, S., Touloumi, O., & Shohami, E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.032 · Cited by 34
The influence of reactive oxygen species on the central nervous system
Gutowicz, M. (2011) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.933486 · Cited by 34
Gomi, M. N., Aoki, T., Takagi, Y., Nishimura, M., Ohsugi, Y., Mihara, M., Nozaki, K., Hashimoto, N., Miyamoto, S., & Takahashi, J. A. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22667 · Cited by 25
Complements, microglial cells and amyloid fibril formation
Ishii, T., & Haga, S. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80043-k · Cited by 25
So, K., Moriya, T., Nishitani, S., Takahashi, H., & Shinohara, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.051 · Cited by 23
Hara, H., Mouri, A., Yonemitsu, Y., Nabeshima, T., & Tabira, T. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.057 · Cited by 16
Cited by
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070
“In addition, within the normal CNS environment, microglia express high levels of microRNA-124, reducing expression of CD46, major histocompatibility complex-II (MHC-II) and CD11b serving to maintain the cells in a quiescent yet, surveillance state (Conrad and Dittel, 2011).”
BackgroundInfluentialNeuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
“demonstrated a distinctive shift from M2 to M1 phenotype of microglial activation [8].”
BackgroundInfluentialThe biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655
Metadata
- Authors
- Varnum, M. M., & Ikezu, T.
- Venue
- Archivum Immunologiae et Therapiae Experimentalis
- Publisher
- Walter de Gruyter GmbH
- Published
- 2012-06-19
- Volume
- 60
- Issue
- 4
- Pages
- 251-266
- ISSN
- 0004-069X (ISSN-L)
- 1661-4917
- OpenAlex
- W2122000781
- Cited by
- 394
- References
- 228
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.